financetom
Business
financetom
/
Business
/
EU code of practice to help firms comply with AI rules will focus on copyright, safety
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU code of practice to help firms comply with AI rules will focus on copyright, safety
Jul 10, 2025 4:52 AM

*

Compliance with AI rules is voluntary

*

But non-signatories will miss legal certainty

*

AI rules to be enforced from August 2026 for new models

(Adds bullet points, background and details)

By Foo Yun Chee

BRUSSELS, July 10 (Reuters) -

A code of practice to help companies comply with the

European Union's landmark AI rules will focus on transparency,

copyright, safety and security, highlighting the EU's push to

set global AI standards amid rapid advancements, the European

Commission said on Thursday.

Signing up to the code is voluntary, but companies that

decline to do so will not benefit from the legal certainty

provided to a signatory.

The comments came as the EU executive presented a final

draft of the guidance, drawn up by 13 independent experts.

The AI rules, which will come into effect in a staggered

manner, will apply to Google owner Alphabet, Facebook

owner Meta, Alphabet's Google, OpenAI,

Anthropic, Mistral and other companies.

The

EU's AI Act

, which came into force last June, imposes strict

transparency obligations on high-risk AI systems, with lighter

requirements for general-purpose AI models.

It restricts governments' use of real-time biometric

surveillance in public spaces to cases linked to certain crimes

or the prevention of terrorist attacks.

The AI rules for large language models (GPAI) will become

legally binding on August 2. It will only be enforced a year

later for new models placed on the market starting from next

month. Existing models will have two years to August 2, 2027 to

comply with the rules.

While the guidance on transparency and copyright will apply

to all GPAI providers, the chapters on safety and security

target providers of the most advanced models such as OpenAI's

ChatGPT, Meta's Llama, Google's Gemini and Anthropic's Claude.

"Co-designed by AI stakeholders, the Code is aligned with

their needs. Therefore, I invite all general-purpose AI model

providers to adhere to the Code. Doing so will secure them a

clear, collaborative route to compliance with the EU's AI Act,"

EU tech chief Henna Virkkunen said.

EU countries and the Commission will need to give the green

light before the code can be implemented, tentatively expected

at the end of the year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Omineca Lode Gold Provides Wingdam Exploration Program Update
Omineca Lode Gold Provides Wingdam Exploration Program Update
Nov 15, 2024
12:27 PM EST, 11/15/2024 (MT Newswires) -- Omineca Mining and Metals ( OMMSF ) on Friday said road access and first drill pads have been completed and diamond drilling is underway at the Wingdam hard rock exploration project located in the Cariboo Mining District of south central British Columbia. The company plans a 10-hole. 4,000-meter, program in downstream of the...
Arbutus Trial of Combination Therapy for Chronic Hepatitis B Shows 'Promising' Results
Arbutus Trial of Combination Therapy for Chronic Hepatitis B Shows 'Promising' Results
Nov 15, 2024
12:27 PM EST, 11/15/2024 (MT Newswires) -- Arbutus Biopharma ( ABUS ) said Friday new data from phase 2a trial of imdusiran followed by Barinthus Biotherapeutics' ( BRNS ) VTP-300 plus a low dose of nivolumab in chronic hepatitis B patients showed promising results. The preliminary data showed that trial participants who received the regimen experienced increased rates of HBsAg...
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Barinthus Biotherapeutics Reports 'Encouraging' Phase 2b HBV003 Trial Results for Chronic Hepatitis B
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- Barinthus Biotherapeutics ( BRNS ) on Friday reported encouraging results from its ongoing phase 2b HBV003 trial for chronic hepatitis B. The study, involving 121 participants, assessed VTP-300 in combination with a low dose of anti-PD1 antibody nivolumab, and new data shows eight participants achieved complete HBsAg loss, while two met the criteria...
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Update: Market Chatter: General Motors Plans to Cut 1,000 Salaried Workers
Nov 15, 2024
12:29 PM EST, 11/15/2024 (MT Newswires) -- (Updates with General Motors' ( GM ) comment in the second paragraph.) General Motors ( GM ) is planning to cut around 1,000 salaried positions globally in an attempt to streamline its operations, Bloomberg reported Friday, citing people familiar with the matter. In order to win in this competitive market, we need to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved